Publication | Open Access

RTOG protocol 92-02: A phase III trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate

UrologyGenitourinary CancerMedicinePhase Iii TrialNeoadjuvant Hormonal CytoreductionProstatic DiseaseAdvanced CarcinomaOncologyRadiation OncologyEndocrine-related Cancer